OVARIAN CANCER

I. Overview

With the aging of the global trend of development, improve the economic status of women, more and more women start hormone replacement therapy (Hormone Replacement Therapy, HRT), to improve access to after menopause due to the decrease in the level of sex hormones related to various diseases. Clear evidence that: postmenopausal women with age, the incidence of coronary heart disease increased by about four times the fracture due to osteoporosis by 20%, died of complications due to pelvic fracture rate of 30%, after the 65-year-old Alzheimer's incidence rate increase every year <BR> and Application HRT can peer groups coronary heart disease risk 50% Alzheimer's risk reduced three times, especially worth mentioning is significantly reduced the incidence of rectal cancer. Long-term use of HRT cancer risk reduced year by year. HRT can also greatly improve the menopause, postmenopausal women with disease or ovarian surgery, radiotherapy in patients with a series of artificial menopause syndrome.

Tags: age, benign, blood, body, brca1, breast, cancer, carcinoma, care, cases, cause, cell, cells, clinical, cyst, cystic, diagnosis, diet, drug, early, eat, ert, estrogen, family, fat, gene, grams, group, groups, growth, gynecological, history, hrt, incidence, increased, injection, intravenous, life, lymph, malignant, metastasis, method, mutation, node, ovarian, patients, pelvic, positive, protein, quality, radiotherapy, rate, reduce, residual, risk, screening, second, study, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, tumors, usually, uterine, women

Cytoreductive surgery in the treatment of ovarian cancer Comprehensive Application and prospects

Foreign Medical Obstetrics and Gynecology volumes in 1999 Vol 26 No. 2

Tianjin Medical University General Hospital of Obstetrics and Gynecology (300,052) of the new QU (Summary) if Mi (revision)

Abstract <BR> since the 1980s, complete cytoreductive surgery to cisplatin-based combination chemotherapy for ovarian cancer as a conventional model, cytoreductive surgery is the complete impact of the prognosis of patients with one of the important factors for recurrent ovarian cancer once again cytoreductive surgery still some value , but to improve the survival rate of patients is more important to be effective after chemotherapy treatment as a necessary complement. Early ovarian cancer retroperitoneal lymph node dissection is reasonable and significance of the still controversial.

Tags: abdominal, age, annex, anti, bleeding, blood, cancer, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, diagnosis, drug, drugs, early, eat, ert, exploration, gene, growth, incidence, increased, intraperitoneal, intravenous, life, lymph, malignant, metastasis, metastatic, method, mutation, node, ovarian, p53, patients, pelvic, physical, poor, positive, prognosis, quality, rate, reduce, resection, residual, response, second, staging, study, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors

The researchers are aware, thoroughly treatment of uterine fibroids and ovarian cysts, breast lumps on the need to completely wipe out "derivative yuan Presents" and started to look for such drugs, "Xiao Rong in the film" get this problem solved. "Xiao Rong in the film" treatment of uterine fibroids and ovarian cysts, breast lumps divided into two steps.

First step: Xiao Rong in the first film screen blood infiltration technology, unique "crystal oxygen segregation" was targeted identification of blood plasma state slot, strong penetration of high density "blood barrier," sever all "derivative yuan Presents" oxygen supply guide "derivative yuan Presents" among phagocytic cells , forcing "derivative yuan Presents" overall contraction, layers and disintegrate, thus achieving a comprehensive system of female physiological turnaround.

Tags: blood, breast, cell, cells, cyst, cysts, drug, drugs, eat, ovarian, rate, second, therapy, treatment, uterine

Ovarian cancer mortality first Habitat gynecologic malignancies, as misprision of onset, 70% of patients when treatment is already advanced. Surgery and chemotherapy comprehensive application is the treatment of advanced ovarian cancer, especially epithelial ovarian cancer therapy of choice. Platinum drug resistance ovarian cancer is the main reason for treatment failure. To solve this problem, clinical oncologist to a variety of solutions, is chosen in 2003 after the open literature on the following:

Tags: anti, cancer, carboplatin, cases, cell, cells, chemotherapy, cisplatin, clinical, csa, days, dose, drug, drugs, eat, head, injection, intravenous, method, ovarian, paclitaxel, patients, positive, rate, reduce, response, study, surgery, survival, therapy, time, toxicity, treatment

[Summary]

Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus, which ranked third. But ovarian cancer death, accounts of the first gynecologic tumors, right pose a serious threat to women's lives. Because ovarian embryonic development, organization anatomy and endocrine function more complicated, it may be suffering from benign tumors or malignant. Because of early ovarian cancer in asymptomatic, and the identification of its type benign and malignant very difficult, ovarian carcinoma laparotomy in ovarian tumor confined to only 30%, most have spread to the uterus, bilateral annex, the omentum and pelvic organs, both in the diagnosis of ovarian cancer and governance the treatment is a major problem indeed. Over the years experts on the pathological form of ovarian cancer, the development of clinical and treatment programs for many of accumulated a lot of experience, so far, statistics on domestic and foreign clinical data, the five-year survival rate of only 25% to 30%.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, care, cases, cause, cell, cells, chemotherapy, clinical, cyst, cystic, days, diagnosis, dose, drug, drugs, early, eat, ert, estrogen, examination, exploration, gene, grams, growth, gynecological, history, incidence, increased, injection, intraperitoneal, intravenous, irradiation, life, lymph, malignant, mass, metastasis, method, node, oppression, ovarian, ovary, pain, patients, pelvic, poor, prognosis, protein, radiation, radiotherapy, rate, reduce, resection, residual, screening, staging, surface, surgery, surgical, survival, symptoms, syndrome, therapy, time, toxicity, treatment, tumor, tumors, uterine, women

Kikuchi, the Japanese report, have received platinum multidrug chemotherapy for recurrent ovarian cancer Japanese women, a weekly carboplatin and paclitaxel chemotherapy in a meeting, can significantly prolong survival, and patients can be tolerated. (Int J Cancer YORK 2005,15:45)

The case control study included surgery and platinum-based adjuvant chemotherapy complete remission for at least 6 months after the recurrence of ovarian cancer patients. Of the 68 patients, 27 patients received a weekly meeting of Taxol and carboplatin chemotherapy (WTJ) (Group I), carboplatin (AUC area under the curve for 2) plus paclitaxel (80 mg/m2); The remaining 41 patients (Group II) to platinum-based (P ) other chemotherapy, 37 patients with CAP program, a monthly meeting of carboplatin and paclitaxel program four cases.

Tags: cancer, carboplatin, cases, chemotherapy, clinical, drug, drugs, eat, family, gene, group, growth, increased, intraperitoneal, method, ovarian, ovary, p53, paclitaxel, patients, preventive, prognosis, protein, rate, risk, screening, second, study, surgery, survival, syndrome, taxol, therapy, time, treatment, women

Laparoscopic surgery with trauma, quick recovery, less adhesions, patients susceptible to the advantages. But for endometrial ovarian cyst, it can completely replace the laparoscopic abdominal operation, has not been determined.

Tags: abdominal, age, benign, bleeding, cause, cyst, cystic, cysts, diagnosis, drug, eat, ert, life, method, ovarian, patients, pelvic, physical, second, surgery, time, treatment

Patients with advanced ovarian cancer treatment to control the tumor growth of its main purposes. At present, surgery, radiotherapy and chemotherapy combined to extend the lives of patients possible. While all patients with adjuvant therapy will bring immediate or long-term side effects of the drug. Cancer, unlike other diseases, and its body damage caused by the spirit even more than the physical damage it causes. Quality of life can be better described in patients with cancer and its treatment on the impact. Clinical workers, and can help patients with the disease in different stages of choosing a more favorable treatment programs; The prognosis there was no significant difference Under the circumstances, can improve the quality of life in patients with treatment programs. Quality of life can be interpreted in two ways: Mental and physical and social aspects of health-related areas. Referring to the quality of life not only in a certain aspect, it is multifaceted materials were summed up.

Tags: age, body, cancer, cause, chemotherapy, clinical, drug, eat, ert, grams, growth, life, ovarian, pain, patients, physical, prognosis, quality, radiotherapy, rate, surgery, survival, therapy, treatment, tumor

Currently, the incidence rates of ovarian cancer accounts for gynecologic malignancy in 23% ~ 27% as the world's five largest high cancer mortality leapt gynecologic tumors in the first place. It can happen to women of any age, but occurred in the before and after menopause, about half occurred after the age of 65.

Tags: administration, age, body, cancer, cause, cell, cells, chemotherapy, clinical, diagnosis, drug, early, eat, ert, examination, gene, gynecological, incidence, intraperitoneal, life, metastasis, method, ovarian, patients, pelvic, quality, radiotherapy, rate, resection, residual, surgery, surgical, survival, symptoms, therapy, time, treatment, tumor, tumors, women

NEW YORK - According to Reuters

A large-scale study showed that the use of drugs to stimulate ovulation and secondary ovarian cancer are not so much.

"Our conclusion is, as previously indicated that some of the limitations of the Institute, as it basically reassuring, confirmed that the use of ovulation-no greater risk of ovarian cancer," the first study, the National Cancer Institute Brinton (Louise A. Robinson), told Reuters . He and his colleagues in the 12,193 women conducted a retrospective cohort study by the above findings. These women average 30-year-old rose - 1988 between infertile because accept the assessment.

Tags: age, cancer, cases, cause, drug, drugs, eat, ert, gene, incidence, increased, ovarian, rate, risk, second, study, time, usually, women